Lepu Biopharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	513.64	426.02	669.4	155.17	402.87	188.55
Short-Term Investments	-	8.78	8.81	59.07	27.87	2.87
Trading Asset Securities	63.63	63.63	-	-	330.66	-
Cash & Short-Term Investments	577.27	498.43	678.2	214.24	761.4	191.42
Cash Growth	-0.72%	-26.51%	216.57%	-71.86%	297.77%	-
Accounts Receivable	26.66	37.8	3.04	-	-	-
Other Receivables	117.88	17.37	22.3	0.07	0.12	-0.45
Receivables	144.54	55.17	25.34	0.07	0.12	-0.45
Inventory	22.28	29.41	24.06	24.18	19.57	8.08
Prepaid Expenses	-	89.36	81.62	73.34	62.27	15.31
Other Current Assets	-	4.78	3.58	2.3	-	7.19
Total Current Assets	744.08	677.15	812.8	314.13	843.35	221.54
Property, Plant & Equipment	1,078	1,087	1,039	978.44	770.04	461.83
Long-Term Investments	122.65	126.69	122.39	137.97	160.29	169.88
Goodwill	-	52.64	52.64	52.64	52.64	52.64
Other Intangible Assets	432.9	381.59	398.18	422.45	445.29	464.7
Other Long-Term Assets	63.68	59.01	104.1	176.43	152.01	154.7
Total Assets	2,441	2,384	2,529	2,082	2,424	1,525
Accounts Payable	228.05	207.61	166.13	158.82	42.45	31.68
Accrued Expenses	-	32.88	32.51	23.96	20.65	9.82
Short-Term Debt	-	393.98	329.63	40.41	-	778.11
Current Portion of Long-Term Debt	499.61	40.32	30.36	20	-	-
Current Portion of Leases	26.47	28.34	37.17	22.91	22.28	30.4
Current Income Taxes Payable	-	1	1.51	1.94	0.91	0.42
Current Unearned Revenue	-	-	-	4	2	2
Other Current Liabilities	231.68	195.43	246.49	277.02	293.94	363.2
Total Current Liabilities	985.81	899.56	843.79	549.06	382.22	1,216
Long-Term Debt	230	260	290.06	232.47	147.27	118.27
Long-Term Leases	18.8	24.18	3.09	19.48	33.53	48.25
Long-Term Unearned Revenue	12	12	12	12	12	12
Long-Term Deferred Tax Liabilities	37.69	37.69	37.69	37.69	37.69	37.69
Other Long-Term Liabilities	254.7	262.17	441.79	384.29	309.18	279.08
Total Liabilities	1,539	1,496	1,628	1,235	921.89	1,711
Common Stock	1,711	1,659	1,659	1,532	1,493	1,000
Additional Paid-In Capital	-	2,420	2,420	1,842	1,620	-
Retained Earnings	-2,546	-2,354	-2,331	-1,642	-631.44	-542.42
Treasury Stock	-	-	-	-	-	-347.45
Comprensive Income & Other	1,750	-828.8	-847.04	-894.2	-1,008	-462.63
Total Common Equity	914.75	896.91	900.76	836.71	1,474	-352.5
Minority Interest	-12.74	-8.21	-	10.37	28.21	166.86
Shareholders' Equity	902.01	888.7	900.76	847.08	1,502	-185.64
Total Liabilities & Equity	2,441	2,384	2,529	2,082	2,424	1,525
Total Debt	774.88	746.82	690.3	335.26	203.08	975.03
Net Cash (Debt)	-197.62	-248.4	-12.1	-121.03	558.32	-783.61
Net Cash Per Share	-0.12	-0.15	-0.01	-0.08	0.49	-1.21
Filing Date Shares Outstanding	1,711	1,659	1,659	1,659	1,532	648.9
Total Common Shares Outstanding	1,711	1,659	1,659	1,532	1,532	648.9
Working Capital	-241.73	-222.42	-30.99	-234.93	461.13	-994.1
Book Value Per Share	0.53	0.54	0.54	0.55	0.96	-0.54
Tangible Book Value	481.85	462.68	449.95	361.62	975.59	-869.83
Tangible Book Value Per Share	0.28	0.28	0.27	0.24	0.64	-1.34
Buildings	-	45.55	45.55	-	-	-
Machinery	-	365.38	246.16	195.06	175.87	105.09
Construction In Progress	-	628.15	661.64	633.35	386.98	171.42
Leasehold Improvements	-	106.03	105.71	102.42	89.4	65.35

Source: S&P Capital IQ. Standard template. Financial Sources.